President Trump delivered a major speech to describe steps his administration is taking to address the high cost of prescription drugs. Congress should be called on to fix two problems with the federal government’s largest prescription drug program: Medicare Part D. That program has made prescription medicines more affordable for millions of seniors, offering...
Thirty-nine health policy experts and representatives of a broad cross-section of organizations joined in signing a comment letter to the Centers for Medicare and Medicaid Services regarding its proposed rule on Short-Term, Limited-Duration Insurance. They argue that the Obama administration exerted “regulatory overreach” in limiting the sale of short-term policies to 90 days and prohibiting...
One of the impediments to repealing and replacing Obamacare has been a belief by the Congressional Budget Office that substantial federal savings will be achieved by innovative demonstration projects in Medicare, Medicaid, and the Children’s Health Insurance Program called for under the law. The CBO bases this conclusion about these savings not on analyses...
Massachusetts was a leader in expanding Medicaid enrollment under ObamaCare, and now nearly one-third of its residents are on the program meant to provide health…
The issue of prescription drug prices continues to top the list of public concerns about health costs, and Congress and the administration are floating possible policy solutions. Solutions to this complex problem will be most effective if they are targeted and geared toward encouraging rather than undermining competition and innovation in the vibrant 21st...
Prescription drug prices continue to be a hot political issue, with the Trump administration preparing to release an action plan as soon as repeal and replace legislation clears Congress. Mick Mulvaney, who heads the White House budget office and is participating in the talks, floated an idea last week that should quickly be crossed...